Exelixis (EXEL) EBITDA: 2009-2025
Historic EBITDA for Exelixis (EXEL) over the last 15 years, with Jan 2025 value amounting to $604.6 million.
- Exelixis' EBITDA rose 73.83% to $236.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $800.2 million, marking a year-over-year increase of 52.94%. This contributed to the annual value of $604.6 million for FY2025, which is 253.82% up from last year.
- As of FY2025, Exelixis' EBITDA stood at $604.6 million, which was up 253.82% from $170.9 million recorded in FY2023.
- Exelixis' EBITDA's 5-year high stood at $604.6 million during FY2025, with a 5-year trough of $110.1 million in FY2021.
- Over the past 2 years, Exelixis' median EBITDA value was $387.8 million (recorded in 2023), while the average stood at $387.8 million.
- Per our database at Business Quant, Exelixis' EBITDA slumped by 70.21% in 2021 and then soared by 253.82% in 2025.
- Exelixis' EBITDA (Yearly) stood at $110.1 million in 2021, then skyrocketed by 160.46% to $286.7 million in 2021, then decreased by 29.71% to $201.5 million in 2022, then dropped by 15.19% to $170.9 million in 2023, then soared by 253.82% to $604.6 million in 2025.